India should use the Covid crisis as an opportunity and emerge as an innovation hub, not just to tackle Coronavirus , but for any other pandemic, going ahead."India is a power house of innovation with an ecosystem of science and technology, and by providing support, rewarding and strengthening academia and industry partnerships, we can move ahead in diagnostics, vaccines and new medicines”, KG Ananthakrishnan, director general, OPPI (Organisation of Pharmaceutical Producers of India) said at the Bennett University webinar on " Biotech to the Rescue"."We are coming together worldwide to find the solution. Scientific discussions are important and sooner we will have something coming out of research plans. Increasing Covid-19 test capabilities is really important. R&D is working together to develop and scaling up the diagnostic. Many R&D are joining hands to find the treatment such as developing vaccines and having clinical trials together," he said while speaking at a session on 'Vaccines: Development & Delivery’ on Thursday.